Gabather AB (publ) (GABA) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.117x

Based on the latest financial reports, Gabather AB (publ) (GABA) has a cash flow conversion efficiency ratio of -0.117x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-331.00K ≈ $-35.62K USD) by net assets (Skr2.82 Million ≈ $303.48K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Gabather AB (publ) stock valuation for the company's overall valuation and market capitalisation.

Gabather AB (publ) - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Gabather AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Gabather AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Gabather AB (publ) ranked by their cash flow conversion efficiency. See Gabather AB (publ) (GABA) cash flow to debt to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Northern 3 Vct Plc LSE:NTN	-0.021x
Camellia Plc LSE:CAM	-0.059x
Digital Ally Inc NASDAQ:DGLY	-0.047x
SPoT Coffee Ltd V:SPP	-0.020x
KATORO GOLD PLC LS-01 F:622	N/A
AnalytixInsight Inc V:ALY	-0.001x
Goldcliff Resource Corp V:GCN	-0.238x
Lord Resources Ltd AU:LRD	-0.660x

Annual Cash Flow Conversion Efficiency for Gabather AB (publ) (2014–2025)

The table below shows the annual cash flow conversion efficiency of Gabather AB (publ) from 2014 to 2025. View GABA stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr-863.00K ≈ $-92.87K	Skr-7.22 Million ≈ $-777.42K	8.371x	+950.12%
2024-12-31	Skr-4.17 Million ≈ $-449.30K	Skr-3.33 Million ≈ $-358.15K	0.797x	+103.33%
2023-12-31	Skr486.00K ≈ $52.30K	Skr-11.64 Million ≈ $-1.25 Million	-23.957x	-758.22%
2022-12-31	Skr3.44 Million ≈ $369.98K	Skr-9.60 Million ≈ $-1.03 Million	-2.791x	-89.90%
2021-12-31	Skr10.96 Million ≈ $1.18 Million	Skr-16.12 Million ≈ $-1.73 Million	-1.470x	-209.74%
2020-12-31	Skr28.85 Million ≈ $3.10 Million	Skr-13.69 Million ≈ $-1.47 Million	-0.475x	-51.21%
2019-12-31	Skr43.59 Million ≈ $4.69 Million	Skr-13.68 Million ≈ $-1.47 Million	-0.314x	+75.16%
2018-12-31	Skr15.87 Million ≈ $1.71 Million	Skr-20.05 Million ≈ $-2.16 Million	-1.264x	-497.58%
2017-12-31	Skr45.76 Million ≈ $4.92 Million	Skr-9.68 Million ≈ $-1.04 Million	-0.211x	+0.97%
2016-12-31	Skr33.19 Million ≈ $3.57 Million	Skr-7.09 Million ≈ $-762.54K	-0.214x	+50.12%
2015-12-31	Skr12.79 Million ≈ $1.38 Million	Skr-5.47 Million ≈ $-588.95K	-0.428x	-141796.96%
2014-12-31	Skr8.63 Million ≈ $929.25K	Skr-2.60K ≈ $-280.32	0.000x	--

About Gabather AB (publ)

ST:GABA Sweden Drug Manufacturers - Specialty & Generic

Market Cap

$1.76 Million

Skr16.36 Million SEK

Market Cap Rank

#30241 Global

#689 in Sweden

Share Price

Skr0.03

Change (1 day)

+0.75%

52-Week Range

Skr0.02 - Skr0.06

All Time High

Skr71.87